Ellis Sean's Form 4/A amendment
AmendedEntera Bio Ltd. (ENTX) · filed Jul 25, 2022
- Accession no.
- 0001178913-22-002767
- Filed
- Jul 25, 2022
- Rule 10b5-1 plan
- Not on the form (before 2023)
- Original filed
- Jan 19, 2022
This filing lists no transactions. It carries over 1 transaction from the original filing that it did not restate. Open-market purchases total $28.1K.
This amendment restates part of 0001178913-22-000163 (filed Jan 19, 2022). The transactions it did not restate still count and are listed below.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Ellis SeanCIK 0001904752 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
This filing has no transactions of this kind.
Carried over from the original filing
This amendment restates only part of the original filing. The original's other transactions still stand, and the trade tables on Livermore count them under this amendment.
From 0001178913-22-000163 (filed Jan 19, 2022).
Non-derivative securities (Table I)
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 18, 2022 | Ordinary Shares, par value NIS 0.0000769 per share | PPurchaseAcquired | +10,000 | $2.81F1 | +$28,100 | 10,000 | Direct |
Footnotes on the original
The footnotes that the prices of these transactions refer to on the original filing.
- F1
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.80 to $2.85, inclusive. The reporting person undertakes to provide to Entera Bio Ltd., an Israeli company ("Entera Bio"), any security holder of Entera Bio, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.
Referenced by the price of 1 transaction in Table I.
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
This Form 4 amendment is being filed to correct the original Form 4 filed on January 19, 2022. The original Form 4 inadvertently omitted 7,200 ordinary shares held directly by the Reporting Person.